Implementing tablet-based ototoxicity screening in adult respiratory patients
J. Cheong (London, United Kingdom), S. Boreland (London, United Kingdom), B. Belkarty (London, United Kingdom), A. Jones (London, United Kingdom), I. Felton (London, United Kingdom), E. Ukor (London, United Kingdom), J. Stowell (London, United Kingdom), R. Jose (London, United Kingdom), S. Madge (London, United Kingdom), J. Wilkins (London, United Kingdom), E. Frost (London, United Kingdom), P. Premachandra (London, United Kingdom), M. Loebinger (London, United Kingdom), F. Drobniewski (London, United Kingdom), N. Simmonds (London, United Kingdom), A. Shah (London, United Kingdom)
Source: International Congress 2022 – Bronchiectasis
Session: Bronchiectasis
Session type: Oral Presentation
Number: 3752
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Cheong (London, United Kingdom), S. Boreland (London, United Kingdom), B. Belkarty (London, United Kingdom), A. Jones (London, United Kingdom), I. Felton (London, United Kingdom), E. Ukor (London, United Kingdom), J. Stowell (London, United Kingdom), R. Jose (London, United Kingdom), S. Madge (London, United Kingdom), J. Wilkins (London, United Kingdom), E. Frost (London, United Kingdom), P. Premachandra (London, United Kingdom), M. Loebinger (London, United Kingdom), F. Drobniewski (London, United Kingdom), N. Simmonds (London, United Kingdom), A. Shah (London, United Kingdom). Implementing tablet-based ototoxicity screening in adult respiratory patients. 3752
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|